REFERENCE
Goldstein A.Chief U.S. drug regulator backs off-label prescribing. Internet Document: [3 pages], 6 Mar 2007. Available from: URL: http://www.bloomberg.com
Rights and permissions
About this article
Cite this article
According to the chief US drug regulator, Andrew von Eschenbach, the US government should not interfere. Pharmacoecon. Outcomes News 525, 2 (2007). https://doi.org/10.2165/00151234-200705250-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705250-00002